These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 8021378)

  • 1. Kava dermopathy.
    Norton SA; Ruze P
    J Am Acad Dermatol; 1994 Jul; 31(1):89-97. PubMed ID: 8021378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kava consumption and its health effects.
    Gounder R
    Pac Health Dialog; 2006 Sep; 13(2):131-5. PubMed ID: 18181402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hematogenous contact eczema cause by phytogenic drugs exemplified by kava root extract].
    Süss R; Lehmann P
    Hautarzt; 1996 Jun; 47(6):459-61. PubMed ID: 8767662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Piper methysticum (kava kava).
    Altern Med Rev; 1998 Dec; 3(6):458-60. PubMed ID: 9855570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health policy versus kava (Piper methysticum): Anxiolytic efficacy may be instrumental in restoring the reputation of a major South Pacific crop.
    Thomsen M; Schmidt M
    J Ethnopharmacol; 2021 Mar; 268():113582. PubMed ID: 33189846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Herbal medicines in Hawaii from tradition to convention.
    Norton SA
    Hawaii Med J; 1998 Jan; 57(1):382-6. PubMed ID: 9509742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kava-induced dermopathy: a niacin deficiency?
    Ruze P
    Lancet; 1990 Jun; 335(8703):1442-5. PubMed ID: 1972218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kava: an overview.
    Singh YN
    J Ethnopharmacol; 1992 Aug; 37(1):13-45. PubMed ID: 1453702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contemporary Pacific and Western perspectives on `awa (Piper methysticum) toxicology.
    Showman AF; Baker JD; Linares C; Naeole CK; Borris R; Johnston E; Konanui J; Turner H
    Fitoterapia; 2015 Jan; 100():56-67. PubMed ID: 25464054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Kava-kava preparations--alternative anxiolytics].
    Nowakowska E; Ostrowicz A; Chodera A
    Pol Merkur Lekarski; 1998 Mar; 4(21):179-180a. PubMed ID: 9640076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Traditional preparations of kava (Piper methysticum) inhibit the growth of human colon cancer cells in vitro.
    Einbond LS; Negrin A; Kulakowski DM; Wu HA; Antonetti V; Jalees F; Law W; Roller M; Redenti S; Kennelly EJ; Balick MJ
    Phytomedicine; 2017 Jan; 24():1-13. PubMed ID: 28160848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic and pharmacodynamic drug interactions with Kava (Piper methysticum Forst. f.).
    Anke J; Ramzan I
    J Ethnopharmacol; 2004 Aug; 93(2-3):153-60. PubMed ID: 15234747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kava dermopathy in Fiji: an acquired ichthyosis?
    Hannam S; Murray M; Romani L; Tuicakau M; J Whitfeld M
    Int J Dermatol; 2014 Dec; 53(12):1490-4. PubMed ID: 25069767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigating volatiles as the secondary metabolome of Piper methysticum from root powder and water extracts using comprehensive two-dimensional gas chromatography.
    Cheung C; Baker JD; Byrne JM; Perrault KA
    J Ethnopharmacol; 2022 Aug; 294():115346. PubMed ID: 35533912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of flavokavins (A, B, C) in cultivars of kava (Piper methysticum) using high performance thin layer chromatography (HPTLC).
    Lebot V; Do TK; Legendre L
    Food Chem; 2014 May; 151():554-60. PubMed ID: 24423570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Re-introduction of kava (Piper methysticum) to the EU: is there a way forward?
    Sarris J; Teschke R; Stough C; Scholey A; Schweitzer I
    Planta Med; 2011 Jan; 77(2):107-10. PubMed ID: 20814850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Composition and biological activity of traditional and commercial kava extracts.
    Côté CS; Kor C; Cohen J; Auclair K
    Biochem Biophys Res Commun; 2004 Sep; 322(1):147-52. PubMed ID: 15313185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of platelet MAO-B by kava pyrone-enriched extract from Piper methysticum Forster (kava-kava).
    Uebelhack R; Franke L; Schewe HJ
    Pharmacopsychiatry; 1998 Sep; 31(5):187-92. PubMed ID: 9832350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic potential of kava in the treatment of anxiety disorders.
    Singh YN; Singh NN
    CNS Drugs; 2002; 16(11):731-43. PubMed ID: 12383029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Some visual effects caused by the beverage kava.
    Garner LF; Klinger JD
    J Ethnopharmacol; 1985 Jul; 13(3):307-11. PubMed ID: 4058033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.